- Home
- Publications
- Publication Search
- Publication Details
Title
Neuronal toxicity of efavirenz: a systematic review
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 12, Issue 6, Pages 841-846
Publisher
Informa Healthcare
Online
2013-07-29
DOI
10.1517/14740338.2013.823396
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein-Free Efavirenz Concentrations in Cerebrospinal Fluid and Blood Plasma Are Equivalent: Applying the Law of Mass Action To Predict Protein-Free Drug Concentration
- (2013) L. B. Avery et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS
- (2013) Andrew H. Miller et al. DEPRESSION AND ANXIETY
- Efavirenz and psychosis: Is there a link?
- (2012) Todd G Manning AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Severe efavirenz-induced vacuolar axonopathy complicated by fatal aspiration pneumonia
- (2012) Chris Kenyon et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose
- (2012) Daniel H. Johnson et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro–In Vivo Extrapolation Model
- (2012) M Siccardi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Antiretroviral Treatment of Adult HIV Infection
- (2012) Melanie A. Thompson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiretroviral neurotoxicity
- (2012) Kevin Robertson et al. JOURNAL OF NEUROVIROLOGY
- Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants
- (2012) Emily R. Holzinger et al. Pharmacogenetics and Genomics
- ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients
- (2012) Marelize Swart et al. Frontiers in Genetics
- Brain aging, Alzheimer's disease, and mitochondria
- (2011) Russell H. Swerdlow BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Non-Nucleoside Reverse Transcriptase Inhibitors Efavirenz and Nevirapine Inhibit Cytochrome C Oxidase in Mouse Brain Regions
- (2011) Emilio L. Streck et al. NEUROCHEMICAL RESEARCH
- Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
- (2011) N. Ciccarelli et al. NEUROLOGY
- Drug uptake transporters in antiretroviral therapy
- (2011) Gerard Minuesa et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells
- (2010) Ana Blas-García et al. HEPATOLOGY
- Long-Term Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals (ACTG 5097s)
- (2010) David B. Clifford et al. HIV CLINICAL TRIALS
- Implications of Efavirenz for Neuropsychiatry: A Review
- (2010) G. I. T. Cavalcante et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
- (2010) Robert K. Heaton et al. JOURNAL OF NEUROVIROLOGY
- Impaired Brain Creatine Kinase Activity in Huntington’s Disease
- (2010) S.F. Zhang et al. Neurodegenerative Diseases
- Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort
- (2010) K. R. Robertson et al. NEUROLOGY
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
- (2010) R. K. Heaton et al. NEUROLOGY
- Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients
- (2010) Laure Elens et al. PHARMACOGENOMICS
- The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research
- (2009) Lavanya Varatharajan et al. ANTIVIRAL RESEARCH
- Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries
- (2009) Gary Maartens et al. ANTIVIRAL THERAPY
- Glucuronidation of the Antiretroviral Drug Efavirenz by UGT2B7 and an in Vitro Investigation of Drug-Drug Interaction with Zidovudine
- (2009) A.-S. Belanger et al. DRUG METABOLISM AND DISPOSITION
- Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations
- (2009) Matthijs van Luin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function
- (2009) Julia di Iulio et al. Pharmacogenetics and Genomics
- Drug interactions at the blood-brain barrier: Fact or fantasy?☆
- (2009) Sara Eyal et al. PHARMACOLOGY & THERAPEUTICS
- MRP (ABCC) Transporters-Mediated Efflux of Anti-HIV Drugs, Saquinavir and Zidovudine, from Human Endothelial Cells
- (2008) Mark Eilers et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Effects of the HIV treatment drugs nevirapine and efavirenz on brain creatine kinase activity
- (2008) Emilio L. Streck et al. METABOLIC BRAIN DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search